SRINIVAS AKKARAJU, M.D., PH.D.

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

3 mention(s) identify SRINIVAS AKKARAJU, M.D., PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
aTYR PHARMA INC 2016-04-12 Dr. Akkaraju holds B.A.s in biochemistry and computer science from Rice University. Holds B.A. degrees in biochemistry and computer science, indicating formal education in computer science which is relevant to programming skills.
aTYR PHARMA INC 2017-03-30 He holds B.A.s in biochemistry and computer science from Rice University. Holds a B.A. in computer science and biochemistry, indicating technical education relevant to software and programming.
aTYR PHARMA INC 2018-04-03 Prior to joining Genentech, Dr. Akkaraju was a graduate student at Stanford University, where he received an M.D. and a Ph.D. in Immunology. He holds B.A.s in biochemistry and computer science from Rice University. Dr. Akkaraju holds B.A.s in biochemistry and computer science from Rice University, indicating software-related technical skills.

aTYR PHARMA INC

Filing Date Source Excerpt
2016-04-12 Dr. Akkaraju holds B.A.s in biochemistry and computer science from Rice University.
2017-03-30 He holds B.A.s in biochemistry and computer science from Rice University.
2018-04-03 Prior to joining Genentech, Dr. Akkaraju was a graduate student at Stanford University, where he received an M.D. and a Ph.D. in Immunology. He holds B.A.s in biochemistry and computer science from Rice University.

Data sourced from SEC filings. Last updated: 2026-03-05